Liquidia Corporation to Report Third Quarter 2026 Financial Results on November 10, 2026
Globe Newswire•03/11/2026•08:30 ET
0
Key Highlights
- ➤Liquidia will report third quarter 2026 financial results November 10, 2026
- ➤Live webcast scheduled for 8:30 a.m. Eastern Time with corporate update
- ➤YUTREPIA approved for pulmonary arterial hypertension treatment
- ➤L606 remains in development for PAH and PH-ILD
MORRISVILLE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will report its third quarter 2026 financial results on Tuesday, November 10, 2026. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update.
The webcast will be available on Liquidia’s website at https://liquidia.com/investors/events-and-presentations. A rebroadcast of the event will be available and archived for a period of one year at the same location.
Get started
Create a free account to read the full story.